Jazz Pharmaceuticals plc JAZZ

Set alert

Price alert · JAZZ

All alert types
232.00 USD +17.56 +8.19%

As of Nov 3, 12:47 PM ET

Bid
231.85 × 2
Ask
232.21 × 2
218.53 Day range 233.74
128.80 52-week range 266.38
YTD
+36.47%
1 year
+67.65%
Open
225.37
Prev close
214.44
Mkt cap
15.06B
Vol
718.40K
Avg vol
892.51K
EPS
3.38
P/E
68.64
Div yield
0.00%
More statistics
Low
218.53
High
233.74
Forward P/E
8.51
Beta
0.37
Short ratio
6.86
Inst. own
103.88%
Dividend
0.00
Ex-div date
Earnings
Feb 23, 2027
50-d avg
231.96
200-d avg
216.63
1y target
295.36

3M chart

Chart tools
Interval

Events in this range
  • Sep 11, 2026Rating: UBS · Buy → Buy
  • Sep 30, 2026Rating: Citigroup · — → Buy
  • Oct 7, 2026Rating: Truist Securities · Buy → Buy
  • Oct 8, 2026Rating: RBC Capital · Outperform → Outperform
  • Oct 21, 2026Rating: Morgan Stanley · Overweight → Overweight
  • Oct 28, 2026Rating: JP Morgan · Overweight → Overweight
  • Nov 2, 2026Earnings: -3.88; estimate -4.05; surprise 4.2%
Signals (19)
NameDateAgo
SMA: BullishNov 3, 20263 hours ago
SMA: BullishNov 3, 20263 hours ago
MACD: Buy SignalOct 29, 20265 days ago
MACD: Sell SignalOct 26, 20261 week ago
MACD: Buy SignalOct 23, 20261 week ago
RSI: OversoldOct 16, 20262 weeks ago
RSI: OversoldOct 8, 20263 weeks ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 31, 20262 months ago
SMA: BearishAug 28, 20262 months ago
SMA: BearishAug 26, 20262 months ago
MACD: Sell SignalAug 26, 20262 months ago
MACD: Buy SignalAug 25, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BearishAug 11, 20262 months ago
MACD: Sell SignalAug 7, 20262 months ago
MACD: Buy SignalAug 4, 20263 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 295.36 +27.3% upside
Target (low)
225.00
Target (mean)
295.36
Target (high)
337.00
Ratings (0m) 22 20 buy · 2 hold · 0 sell
  • Strong buy7
  • Buy13
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 22
  • 1 month ago 22
  • 2 months ago 20

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

JAZZ analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-2.38-4.72 – 5.818.13-129.2%1.21B+7.7%13
Next quarter6.565.16 – 8.786.64-1.3%1.24B+3.8%13
Current year15.4913.35 – 24.008.38+84.9%4.74B+11.0%13
Next year25.2013.70 – 31.3915.49+62.6%5.02B+5.9%13

Upgrades and downgrades

The latest rating changes

JAZZ analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026JP MorganMaintainedOverweightOverweight
Oct 21, 2026Morgan StanleyMaintainedOverweightOverweight
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Oct 7, 2026Truist SecuritiesMaintainedBuyBuy
Sep 30, 2026CitigroupInitiated—Buy
Sep 11, 2026UBSMaintainedBuyBuy
Sep 10, 2026BarclaysMaintainedOverweightOverweight
Aug 26, 2026Deutsche BankMaintainedBuyBuy
Aug 26, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 26, 2026Truist SecuritiesMaintainedBuyBuy
Aug 26, 2026NeedhamMaintainedBuyBuy
Aug 11, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 4, 2026JP MorganMaintainedOverweightOverweight
Aug 4, 2026Truist SecuritiesMaintainedBuyBuy
Aug 4, 2026TD CowenMaintainedBuyBuy
Aug 4, 2026Wells FargoMaintainedOverweightOverweight
Aug 4, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 4, 2026Piper SandlerMaintainedOverweightOverweight
Aug 4, 2026NeedhamMaintainedBuyBuy
Aug 4, 2026BarclaysMaintainedOverweightOverweight
Aug 4, 2026BairdMaintainedOutperformOutperform
Jul 20, 2026NeedhamMaintainedBuyBuy
Jul 17, 2026Canaccord GenuityInitiated—Buy
Jul 14, 2026Wells FargoMaintainedOverweightOverweight
Jul 14, 2026BarclaysMaintainedOverweightOverweight
Jul 9, 2026Deutsche BankMaintainedBuyBuy
Jul 7, 2026Truist SecuritiesMaintainedBuyBuy
Jun 10, 2026B of A SecuritiesMaintainedBuyBuy
May 27, 2026BarclaysMaintainedOverweightOverweight
May 22, 2026BernsteinInitiated—Market Perform